BioSpace News Archive

International medical diagnostics company selects Translational Software’s evidence-based PGx content to broaden genetic testing services in Australia

Respected leader brings expertise in immunology and cell therapy

Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results

Myrtle Potter, former President and COO of Genentech, appointed Vant Operating Chair

Cedilla Therapeutics today announced the appointment of veteran biopharma executive Rosana Kapeller, M.D., Ph.D., as an independent member of the board of directors. Kapeller, the former chief scientific officer at Nimbus Therapeutics, brings a wealth of experience in drug discovery, platform validation and corporate leadership.

Allogene Therapeutics, Inc. announced its Scientific Advisory Board (SAB), which is comprised of five experts in oncology, immunology, drug discovery and development.

Correvio Pharma Corp. announced that it has entered into an At the Market Sales Issuance Agreement dated July 10, 2018 (the “Sales Agreement”) with B. Riley FBR, Inc. (“BRFBR”) as agent, pursuant to which the Company may, from time to time sell, through “at-the-market” offerings on the Nasdaq Capital Market

Pursuit Vascular, Inc. reached a milestone in June with the shipment of over 2 million pairs of ClearGuard HD caps during the first 6 months of 2018, an important achievement as the company continues to bring its innovative technology to a broader patient base.

CMTREX is on track to launch an international Cannabis Mercantile Trading Exchange at the upcoming Cannatech Global Summit in Sydney October 28-30.

Expanded Emphasis On Interpreting The Science Of Complex Medical Innovations Bolsters Precision’s Capabilities to Support Commercial And R&D Client Base